- Home
- AVIR vs NEN Comparison
AVIR vs NEN Comparison
Compare AVIR & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
NEN
New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
Current Price
Company Overview
Basic Information| Metric | AVIR | NEN |
|---|---|---|
| Founded | 2012 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 227.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | NEN |
|---|---|---|
| Price | $3.93 | $65.06 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 452.4K | 1.2K |
| Earning Date | 03-05-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 6.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.33 |
| Revenue | N/A | ★ $87,362,592.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.56 |
| Revenue Growth | N/A | ★ 7.63 |
| 52 Week Low | $2.46 | $62.10 |
| 52 Week High | $4.34 | $84.00 |
Technical Indicators
Market Signals| Indicator | AVIR | NEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 47.70 |
| Support Level | $3.75 | $62.41 |
| Resistance Level | $4.15 | $65.30 |
| Average True Range (ATR) | 0.22 | 0.65 |
| MACD | 0.04 | 0.26 |
| Stochastic Oscillator | 58.51 | 65.72 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.